|
1
|
Kim Y, Ge Y, Tao C, Zhu J, Chapman AB,
Torres VE, Yu AS, Mrug M, Bennett WM, Flessner MF, et al:
Consortium for Radiologic Imaging Studies of Polycystic Kidney
Disease (CRISP): Automated segmentation of kidneys from MR images
in patients with autosomal dominant polycystic kidney disease. Clin
J Am Soc Nephrol. 11:576–584. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fox CS, Matsushita K, Woodward M, Bilo HJ,
Chalmers J, Heerspink HJ, Lee BJ, Perkins RM, Rossing P, Sairenchi
T, et al: Chronic Kidney Disease Prognosis Consortium: Associations
of kidney disease measures with mortality and end-stage renal
disease in individuals with and without diabetes: A meta-analysis.
Lancet. 380:1662–1673. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Haynes R, Staplin N, Emberson J,
Herrington WG, Tomson C, Agodoa L, Tesar V, Levin A, Lewis D, Reith
C, et al: SHARP Collaborative Group: Evaluating the contribution of
the cause of kidney disease to prognosis in CKD: Results from the
Study of Heart and Renal Protection (SHARP). Am J Kidney Dis.
64:40–48. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ta MH, Schwensen KG, Foster S, Korgaonkar
M, Ozimek-Kulik JE, Phillips JK, Peduto A and Rangan GK: Effects of
TORC1 inhibition during the early and established phases of
polycystic kidney disease. PLoS One. 11:e01641932016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takahashi-Sato K, Murakawa M, Kimura J,
Ito MA and Matsuoka I: Loss of ectonucleotidases from the coronary
vascular bed after ischemia-reperfusion in isolated rat heart. BMC
Cardiovasc Disord. 68:2577–2584. 2016.
|
|
6
|
Chua S, Lee FY, Tsai TH, Sheu JJ, Leu S,
Sun CK, Chen YL, Chang HW, Chai HT, Liu C, et al: Inhibition of
dipeptidyl peptidase-IV enzyme activity protects against myocardial
ischemia-reperfusion injury in rats. J Transl Med. 19:285–297.
2016.
|
|
7
|
Wang K, Zhang J, Liu J, Tian J, Wu Y, Wang
X, Quan L, Xu H, Wang W and Liu H: Variations in the protein level
of Omi/HtrA2 in the heart of aged rats may contribute to the
increased susceptibility of cardiomyocytes to ischemia/reperfusion
injury and cell death: Omi/HtrA2 and aged heart injury. Age
(Dordr). 30:266–271. 2016.
|
|
8
|
Huang P, Sun Y, Yang J, Chen S, Liu AD,
Holmberg L, Huang X, Tang C, Du J and Jin H: The ERK1/2 signaling
pathway is involved in sulfur dioxide preconditioning-induced
protection against cardiac dysfunction in isolated perfused rat
heart subjected to myocardial ischemia/reperfusion. Int J Mol Sci.
206:26–32. 2016.
|
|
9
|
ONeill KL, Huang K, Zhang J, Chen Y and
Luo X: Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak
through the outer mitochondrial membrane. Genes Dev. 30:973–988.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lindqvist LM, Heinlein M, Huang DC and
Vaux DL: Prosurvival Bcl-2 family members affect autophagy only
indirectly, by inhibiting Bax and Bak. Invest New Drugs.
34:713–725. 2016.
|
|
11
|
Zhang WZ, Li R, Liu S, Zhang JD, Ning XF
and Cai SL: Effects of renal ischemic postconditioning on
myocardial ultrastructural organization and myocardial expression
of Bcl-2/Bax in rabbits. BioMed Res Int. 2016:93494372016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shen S, Wang JF, Wu JQ, Zhou JX, Meng SD,
Ma J, Zhu CL, Deng GG and Liu D: GC/MS-based metabolomic analysis
of alleviated renal ischemia-reperfusion injury induced by remote
ischemic preconditioning. Eur Rev Med Pharmacol Sci. 21:765–774.
2017.PubMed/NCBI
|
|
13
|
Tawfik MK: Renoprotective activity of
telmisartan versus pioglitazone on ischemia/reperfusion induced
renal damage in diabetic rats. Eur Rev Med Pharmacol Sci.
16:600–609. 2012.PubMed/NCBI
|
|
14
|
Park SY, Shrestha S, Youn YJ, Kim JK and
Kim SY: Role of Toll-like receptor-4 in renal graft
ischemia-reperfusion injury. Asian Pac J Trop Med. 9:2–9. 2016.
|
|
15
|
Kierulf-Lassen C, Kristensen ML, Birn H,
Jespersen B and Nørregaard R: No effect of remote ischemic
conditioning strategies on recovery from renal ischemia-reperfusion
injury and protective molecular mediators. BMC Cancer. 16:686–691.
2016.PubMed/NCBI
|
|
16
|
Chen YT, Tsai TH, Yang CC, Sun CK, Chang
LT, Chen HH, Chang CL, Sung PH, Zhen YY, Leu S, et al: Exendin-4
and sitagliptin protect kidney from ischemia-reperfusion injury
through suppressing oxidative stress and inflammatory reaction. J
Transl Med. 11:2702013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Y and Liu S: The effect of
dexmedetomidine on oxidative stress response following cerebral
ischemia-reperfusion in rats and the expression of intracellular
adhesion molecule-1 (ICAM-1) and S100B. Med Sci Monit. 23:867–873.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Batinic-Haberle I, Tovmasyan A, Roberts
ER, Vujaskovic Z, Leong KW and Spasojevic I: SOD therapeutics:
Latest insights into their structure-activity relationships and
impact on the cellular redox-based signaling pathways. Antioxid
Redox Signal. 20:2372–2415. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang L, Gan W and An G: Influence of
Tanshinone IIa on heat shock protein 70, Bcl-2 and Bax expression
in rats with spinal ischemia/reperfusion injury. Neural Regen Res.
7:2882–2888. 2012.PubMed/NCBI
|
|
20
|
Ma Z, Wei Q, Dong G, Huo Y and Dong Z: DNA
damage response in renal ischemia-reperfusion and ATP-depletion
injury of renal tubular cells. Biochim Biophys Acta.
1842:1088–1096. 2014. View Article : Google Scholar : PubMed/NCBI
|
